Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Weekly
Analytics
Innovation and Product Development news
(page 5)
21 October 2025
Takeda Partners with Innovent on Oncology Medicines
Takeda gains rights to two late-stage cancer drugs and an option for an early-stage program, focusing on global development and commercialization outside Greater China.
21 October 2025
Veolia to Operate Chile's First Desalination Plant in Valparaíso
Veolia wins a four-year contract to manage a desalination plant and aqueduct in Chile, focusing on renewable energy and local labor, with potential extensions until 2040.
21 October 2025
BASF and IFF Collaborate on Enzyme and Polymer Innovation
The collaboration aims to develop sustainable enzyme and polymer technologies for cleaning and personal care, enhancing performance and reducing environmental impact.
21 October 2025
Evonik Unveils GMP-Grade EUDRACAP® Colon Capsules at CPHI Frankfurt
EUDRACAP® colon capsules enable precise delivery of sensitive actives to the ileo-colonic region, simplifying drug development and accelerating market entry for innovative therapies.
21 October 2025
Borealis and Promix: Recyclable Packaging for PPWR Compliance
Developed recyclable packaging with Borcycle™ M and Promix Microcell Technology, meeting EU's 2030 PPWR targets for recyclability and recycled content in non-food applications.
20 October 2025
NEXTCHEM to Conduct Feasibility Study for Waste-to-Methanol Project in Norway
The project explores converting waste to low-carbon methanol at Mongstad, aiding compliance with EU regulations for marine and aviation fuels.
News type
New Projects and Expansions
New Projects and Expansions
Project Updates and Milestones
Project Updates and Milestones
Mergers, Acquisitions, and Partnerships
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Innovation and Product Development
Operational Changes and Investments
Operational Changes and Investments
Sustainability and Environmental Initiatives
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Financial Performance and Strategy
Executive Appointments and Governance Changes
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Analytics
Learn more
20 October 2025
Lummus Technology Secures Consecutive Technology Licensor of the Year Award
Lummus also won Best Refining Technology for CDDMESM. They were finalists in four other categories, highlighting their innovation and leadership in the energy sector.
20 October 2025
Merck Begins $3B Pharmaceutical Facility Construction in Virginia
Merck invests $70B in U.S. manufacturing and R&D, creating 500+ full-time and 8,000 construction jobs in Virginia, enhancing biopharmaceutical innovation and domestic production.
20 October 2025
Johnson & Johnson's INLEXZO™ and Cetrelimab Show Promising Pre-Surgical Results in Bladder Cancer
Phase 2b study shows INLEXZO™ plus cetrelimab achieves significant pathologic response rates in muscle invasive bladder cancer patients ineligible for platinum-based chemotherapy.
20 October 2025
Novo Nordisk to Present Oral Semaglutide and Obesity Data at ObesityWeek 2025
New data on oral semaglutide and CagriSema will be presented, focusing on weight loss efficacy, cardiometabolic health, and women's health in obesity management.
20 October 2025
Croda Reveals New Data on KeraBio K31 Hair Repair Innovation
KeraBio K31 offers potent hair repair at low concentrations, enhancing sustainability. It's 99% natural, vegan, and shortlisted for a Product Innovation Award.
20 October 2025
LYB Invests in R&D to Improve Mechanical Recycling Quality
LYB enhances recycling with advanced sorting, decontamination, and analytics for safer, high-quality recyclates, focusing on different technologies for various plastic waste types.
20 October 2025
WuXi Biologics Receives 2025 Global Customer Value Leadership Award from Frost & Sullivan
Recognized for innovation and operational excellence, the company supports 864 projects, achieving a 98% success rate in manufacturing and passing 44 global regulatory inspections.
20 October 2025
Roche's Tecentriq Enhances Survival in Bladder Cancer with ctDNA-Guided Treatment
Tecentriq reduces death risk by 41% and recurrence by 36% in bladder cancer using ctDNA guidance, sparing low-risk patients from unnecessary treatment.
20 October 2025
Roche's Gazyva Approved by FDA for Lupus Nephritis Treatment
FDA approves Gazyva for lupus nephritis, showing superior results in trials, offering a new treatment option to prevent kidney disease progression.
19 October 2025
NEXTCHEM Conducts Feasibility Study for Waste-to-Methanol Project in Norway
The project explores converting waste to low-carbon methanol at Mongstad, aiming to replace marine fuel and produce Sustainable Aviation Fuel.
19 October 2025
Johnson & Johnson's Subcutaneous Amivantamab Shows 45% Response Rate in Head and Neck Cancer
Subcutaneous amivantamab offers rapid, durable responses in head and neck cancer, with 82% tumor shrinkage and a median response duration of 7.2 months.
19 October 2025
Raludotatug Deruxtecan Shows 50.5% Response in Platinum-Resistant Ovarian Cancer, Reports Daiichi Sankyo and Merck
Raludotatug deruxtecan achieved a 50.5% response rate in phase 2 for platinum-resistant ovarian cancer, with a 5.6 mg/kg dose selected for phase 3.
18 October 2025
Genmab Reports Positive Phase 1/2 Trial Results for Rina-S in Advanced Endometrial Cancer
Rina-S shows 50% response rate in advanced endometrial cancer trial; FDA grants Breakthrough Therapy Designation.
18 October 2025
Merck and Eisai: KEYTRUDA and LENVIMA Show 5-Year Survival Benefit in Advanced Endometrial Carcinoma
KEYTRUDA and LENVIMA improve 5-year survival rates in advanced endometrial carcinoma compared to chemotherapy, with consistent results across patient subgroups.
18 October 2025
Merck: KEYTRUDA and Padcev Cut Bladder Cancer Risks Pre- and Post-Surgery
KEYTRUDA and Padcev improve survival rates in muscle-invasive bladder cancer patients ineligible for cisplatin, showing significant event-free and overall survival benefits.
17 October 2025
Roche Unveils Phase III Data for Vamikibart in Uveitic Macular Edema
Vamikibart shows promise in treating UME, with significant vision improvements in trials, offering a non-steroid alternative with fewer side effects.
17 October 2025
FDA Approves Novo Nordisk's Oral Semaglutide for CV Risk Reduction in High-Risk Type 2 Diabetes Adults
Oral semaglutide reduces major cardiovascular events in high-risk type 2 diabetes patients, showing a 14% risk reduction over 4 years, with consistent safety profile.
17 October 2025
Brenntag Opens Food & Nutrition Innovation Center in Leeds
The Leeds center focuses on R&D for food applications, offering ingredient selection, formulation support, and technical solutions for UK and Ireland food manufacturers.
17 October 2025
Roche's Gazyva/Gazyvaro Gains EU CHMP Nod for Lupus Nephritis
CHMP backs Gazyva/Gazyvaro for lupus nephritis, showing superior renal response in trials. Awaiting European Commission decision.
17 October 2025
Heidelberg Materials Launches evoZero, Carbon-Captured Cement in Europe
evoZero, a near-zero carbon cement, is now available in Europe, verified by DNV, supporting sustainable projects like Skøyen Station and DREIHAUS.
17 October 2025
Mitsubishi Gas Chemical and Cirena Agree on Japan Distribution for Long-Chain RNA
MGC and Cirena to negotiate exclusive Japan distribution for long-chain RNA, enhancing MGC's nucleic acid pharmaceutical efforts.
17 October 2025
Mitsubishi Chemical's SoarnoL EVOH Resins Approved for Recyclability in Multilayer Films
RecyClass confirms multilayer films with up to 10% SoarnoL EVOH resins are recyclable with PE flexibles, supporting sustainable packaging and circular economy efforts.
16 October 2025
BASF Launches High-Purity Isobionics® Natural Lime Flavor Ingredient
Isobionics® Natural alpha-Farnesene 95 offers high purity for lime applications, is fermentation-based, and meets EU/US food regulations. Suitable for beverages, sweets, and citrus flavors.
16 October 2025
Aptar Digital Health's HeroTracker Sense Gains FDA 510(k) Clearance
HeroTracker Sense, a Bluetooth sensor for inhalers, gets FDA clearance, enhancing asthma and COPD management with real-time tracking and personalized support for patients aged 12 and above.
← Previous
Next →
